Prognostic signature and immune efficacy of m(1)A‐, m(5)C‐ and m(6)A‐related regulators in cutaneous melanoma

Cutaneous melanoma (CM) is an aggressive cancer; given that initial and specific signs are lacking, diagnosis is often late and the prognosis is poor. RNA modification has been widely studied in tumour progression. Nevertheless, little progress has been made in the signature of N(1)‐methyladenosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xian rui, Chen, Zheng, Liu, Yang, Chen, Zi zi, Tang, Fengjie, Chen, Zhi zhao, Li, Jing jing, Liao, Jun lin, Cao, Ke, Chen, Xiang, Zhou, Jianda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419166/
https://www.ncbi.nlm.nih.gov/pubmed/34288419
http://dx.doi.org/10.1111/jcmm.16800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419166/
https://www.ncbi.nlm.nih.gov/pubmed/34288419
http://dx.doi.org/10.1111/jcmm.16800

Ejemplares similares